BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Lung
,
Alcohol
,
Valproic acid
,
rs3825942
,
LEP
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Aptivus
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
A Review on Pharmacokinetics Properties of Antiretroviral Drugs to Treat HIV-1 Infections.
European Commission grants full approval for Aptivus.
FDA notifications. Tentative approval to Aptivus for combination ART.
Intracranial hemorrhage with Aptivu.
Aptivus capsules granted full FDA approval.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions,…
Observational Non-interventional Study (Anwendungsbeobachtung) With AptivusĀ® (Tipranavir) in HIV-inf…
A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-admini…
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ